about
Human Immunodeficiency Virus Playing Hide-and-Seek: Understanding the TFH Cell Reservoir and Proposing Strategies to Overcome the Follicle SanctuaryTherapeutic Applications of Rose Hips from Different Rosa Species.HIV and HCV Medications in End-Stage Renal Disease.Potent Inhibitors Active against HIV Reverse Transcriptase with K101P, a Mutation Conferring Rilpivirine Resistance.Discovery of BMS-955176, a Second Generation HIV-1 Maturation Inhibitor with Broad Spectrum Antiviral Activity.Altered Plasmodium falciparum Sensitivity to the Antiretroviral Protease Inhibitor Lopinavir Associated with Polymorphisms in pfmdr1.Inhibition of Plasmodium Hepatic Infection by Antiretroviral Compounds.Barriers to sexually transmitted infection testing in New Zealand: a qualitative study.Pharmacogenetic considerations in the treatment of HIV.Differences in genetic variants in lopinavir disposition among HIV-infected Bantu Africans.HIV psychiatry in the era of combined antiretroviral therapy: top five issues.CD4 Lymphocyte Enumeration and Hemoglobin Assessment Aid for Priority Decisions: A Multisite Evaluation of the BD FACSPresto™ System.Off-Target Effects of Drugs that Disrupt Human Mitochondrial DNA Maintenance.Structure of HIV-1 reverse transcriptase cleaving RNA in an RNA/DNA hybrid.Differentiation and Function of Follicular CD8 T Cells During Human Immunodeficiency Virus Infection.PharmGKB summary: atazanavir pathway, pharmacokinetics/pharmacodynamics
P2860
Q33742139-48743ED1-590A-4A72-8C52-1A500EA896ABQ33838470-AD7D67B3-3985-4274-8747-4867B17196F7Q35832564-EB495A0D-D2B3-4F78-9785-08C2B909946BQ36146704-AB18D944-7B2A-455B-A47D-59A633BAD61CQ36996295-2C213651-3630-4582-874A-D1D3F1C01991Q37538658-F122B8CF-8D4B-421B-AB54-6EDFE2624611Q38695833-D3AD1119-E6C7-428A-9241-A4A6EA8673A3Q38700835-12790B39-656E-485D-8510-5D0586C55B61Q38782609-78913E79-0BA8-4E3B-A826-B6CB965F230CQ40688836-79E60D75-2B93-445C-8D8C-A4CAE78939A6Q43184136-FD1E49FD-B947-45F4-9CB0-C81D00A07CCBQ47095733-4CDFFC75-7B5C-402C-BBD2-E80EDF068A0EQ47125109-B8AFBC4F-134A-4F76-B65D-DA0353427643Q47558759-75E6EFDC-7582-450C-8DF7-67C22C0FAD95Q55365295-D4F081D1-3CFF-495C-A837-26AC265FEA7FQ57403878-8BF56B6B-DB4F-4C15-962A-3A640CE9334D
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Antiretroviral therapy: current drugs
@ast
Antiretroviral therapy: current drugs
@en
Antiretroviral therapy: current drugs
@nl
type
label
Antiretroviral therapy: current drugs
@ast
Antiretroviral therapy: current drugs
@en
Antiretroviral therapy: current drugs
@nl
prefLabel
Antiretroviral therapy: current drugs
@ast
Antiretroviral therapy: current drugs
@en
Antiretroviral therapy: current drugs
@nl
P2860
P1476
Antiretroviral therapy: current drugs
@en
P2093
Alice K Pau
Jomy M George
P2860
P304
P356
10.1016/J.IDC.2014.06.001
P577
2014-09-01T00:00:00Z